title: Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.
abstract: Delusional disorder, somatic type (DDST) is a rare psychiatric disorder and the treatment is mostly based on observations, due to the lack of well-organized studies. Initially, antipsychotics and especially pimozide were considered to be the pharmacological approach of choice but, subsequently, tryciclic anti-depressants and selective serotonin re-uptake inhibitors (SSRIs) were also suggested to be effective, implicating the serotonergic system in the pathophysiology of the disorder. We present the case of a female with DDST, who responded to aripiprazole-mirtazapine combination, a finding that is in accordance with the initial approach of this disorder as a part of the schizophrenic spectrum, but also supports the hypothesis of serotonin dysfunction in DDST.
authors.affiliation: Psychiatric Clinic, "Asklepeion" Hospital, Athens, Greece. dmpnikos@yahoo.gr
authors.forename: N P
authors.initials: NP
authors.lastname: Dimopoulos
authors.forename: C I
authors.initials: CI
authors.lastname: Mitsonis
authors.forename: V V
authors.initials: VV
authors.lastname: Psarra
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D004359:Drug Therapy, Combination; D004651:Employment; D005260:Female; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012919:Social Behavior
chemical_list: D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D008803:Mianserin; D000068180:Aripiprazole; D000078785:Mirtazapine